Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Z H, Siddik"'
Autor:
Z. H. Siddik, S. P. Tomasovic
Publikováno v:
International Journal of Hyperthermia. 13:257-259
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 7(11)
1R,2R-Diaminocyclohexane(trans-diacetato)(dichloro)-platinum(IV) (DACH-acetato-Pt) is a novel platinum-based agent that is highly effective against cisplatin-resistant ovarian tumor cells. To probe its cellular mechanism, the effects of DACH-acetato-
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 6(1)
Cell cycle regulators and signal transduction pathways can influence apoptotic sensitivity of tumor cells, and we previously described an association between EGFr overexpression, reduced DNA repair activity, and increased apoptotic sensitivity of ME-
Autor:
T, Furui, R, LaPushin, M, Mao, H, Khan, S R, Watt, M A, Watt, Y, Lu, X, Fang, S, Tsutsui, Z H, Siddik, R C, Bast, G B, Mills
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 5(12)
Lysophosphatidic acid (LPA) is one of the major growth factors in ascites from ovarian cancer patients and appears to play an important role in proliferation, survival, and invasion of ovarian cancer cells. Recently, several groups have shown that Ed
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 5(3)
The compound (1R,2R-diaminocyclohexane)(transdiacetato)(dichloro)platinum(IV) (DACH-acetato-Pt) is a novel platinum-based antitumor agent with clinical potential against cisplatin-resistant disease that is under development in our laboratory. In view
Publikováno v:
Cancer research. 58(4)
The p53 tumor suppressor gene is critical in regulating cell proliferation following DNA damage, and disruption of p53 protein function by mutation has been implicated as a factor responsible for resistance of tumor cells to chemotherapeutic agents.
Autor:
R, Perez-Soler, D M, Shin, Z H, Siddik, W K, Murphy, M, Huber, S J, Lee, A R, Khokhar, W K, Hong
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 3(3)
cis-Bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(II) (NDDP) is a lipophilic non-cross-resistant platinum compound formulated in large multilamellar liposomes (1-3 micrometer). The maximum tolerated dose (MTD) of liposomal-entrapped NDDP
Publikováno v:
Anti-cancer drug design. 9(6)
A platinum(II) and three platinum(IV) ammine/cycloalkylamine homologous series, the latter possessing either chloro, acetato or hydroxo axial ligands, were evaluated for efficacies in mice bearing tumor cells sensitive (leukemia L.1210/0 and reticulo
Publikováno v:
Anti-cancer drug design. 9(5)
Ammine/amine dichloroplatinum(II) complexes have been evaluated for structure-activity relationship in wild-type L1210/0, 185-fold cisplatin-resistant L1210/DDP and 39-fold tetraplatin-resistant L1210/DACH murine leukemia cells. The mechanism of resi
Publikováno v:
Cancer research. 54(17)
A platinum(II) and 3 platinum(IV) ammine/cycloalkylamine homologous series were evaluated for cytotoxicity and biochemical pharmacology in murine leukemia L1210/0, cis-diamminedichloroplatinum(II)- resistant L1210/DDP, and diaminocyclohexaneplatinum-